Realizing the Opportunity of : How Do We Accelerate the Revolution?
The benefits of wider routine use of CGP and molecularly guided therapy, identify the barriers that are preventing its broader adoption, and how these can be overcome at a clinical practice and healthcare systems level.
Molecularly Guided Therapy in Oncology Practice: The Evolving State of the Art
The latest advances in circulating tumor DNA (ctDNA) testing and RNA sequencing and the implications to application of molecularly targeted therapy in routine practice.
